|
A Phase II Clinical Trial of ENMD-2076 in Metastatic Triple-Negative Breast Cancer: Translating a P53-Based Biomarker from Bench to Bedside |
|
|
|
Titel: |
A Phase II Clinical Trial of ENMD-2076 in Metastatic Triple-Negative Breast Cancer: Translating a P53-Based Biomarker from Bench to Bedside |
Auteur: |
Diamond, J.R. Tan, A.C. Pitts, T.M. van Bokhoven, A. Aisner, D. Elias, A.D. Borges, V.F. Miller, K.D. Eckhardt, S.G. Tentler, J.J. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 24 () nr. S1 pagina's i36 |
Jaar: |
2013 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|